natasharekhtman Profile Banner
Natasha Rekhtman MD PhD Profile
Natasha Rekhtman MD PhD

@natasharekhtman

Followers
6K
Following
2K
Media
357
Statuses
2K

Thoracic pathologist and cytopathologist at Memorial Sloan Kettering Cancer Center

Joined March 2012
Don't wanna be here? Send us removal request.
@natasharekhtman
Natasha Rekhtman MD PhD
6 years
Yay! Thrilled eBook is finally out. Thanks a million to my main partners @mkbaine and @ENTpathology, and many brilliant contributors for making this possible. #pathology #pathboards #KnowOrFail
Tweet media one
42
78
390
@natasharekhtman
Natasha Rekhtman MD PhD
28 days
Welcome to @MSKPathology to our new fellows! Look forward to working with all of you :).
@rovingatuscap
Samson W. Fine, MD
29 days
Excited to welcome 🎉 a new class of Oncologic Surgical & Subspecialty Fellows to @MSKPathology - looking forward to a wonderful 2025-2026 academic year!
Tweet media one
2
1
19
@natasharekhtman
Natasha Rekhtman MD PhD
3 months
First #PathFellowship Open House at @MSKPathology. Please join us!.
@MSKPathology
MSK Department of Pathology & Laboratory Medicine
3 months
Join our Virtual #PathFellowship Open House!.Monday, May 12th 5:00-6:30 pm (EST).Register at this link and spread the word! Breakout Rooms with program directors -.Oncologic Surgical Pathology.Bone/ST.Breast.Cytopath.Dermpath.GI .GU .GYN .Hemepath.Thoracic
Tweet media one
2
6
17
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
Hi all! WOW. Dan @DanGrahamMD, you nailed it right out of the gate!! 🏆 Indeed - this is mucinous lung adeno and . admixed metastatic prostate cancer. Example of many collisions of various tumors that can occur in the lung. Not sure if AI would ever get this, but can't get
Tweet media one
1
5
28
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
Hi, #pulmpath friends!.Ready to try your hand (meaning eye) at this case?.3 cm lung nodule. 🔬🧩.#NatPathPuzzler #PathTwitter
Tweet media one
Tweet media two
Tweet media three
7
23
81
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
Thrilled to have had the opportunity to present our work on unusual #SCLC that appears to be evolving from pulmonary carcinoids #NET via unique molecular mechanisms at #SCLC25. Thanks for the post, @SclcSMASHERS!.
@LUNGevity
LUNGevity Foundation
4 months
Always great to hear about @natasharekhtman @MSKCancerCenter elegant work on biology of different subtypes of small cell cancers. ICYMI her publication can be found here: @SclcSMASHERS #SCLC24
Tweet media one
0
3
20
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
Was a great honor to serve as a co-chair of @IASLC #SCLC25 hot topics meeting. Thanks to all participants for making this such an informative, inspiring, and inclusive meeting. #SCLC
Tweet media one
0
3
28
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
So proud of our amazing @MSKPathology thoracic pathology fellows for their great presentations at @TheUSCAP 25. Great job Jonathan Willner, Maelle Saliba @saliva, and Harshita Mehrotra @hmehrot1!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
7
64
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
#USCAP2025 is a wrap! Was so great to see so many old and new friends. Thrilled to have had a chance to organize Pulmonary Evening Conference . Thanks to everyone who attended, and many thanks to Kirk Jones, Marina Baine @mkbaine, Charles Leduc @thoracicpath and Joanne Yi for
Tweet media one
2
2
35
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
RT @PulmPathSoc: Join us for the PPS Poster Walks at #USCAP2025!.Discover cutting edge insights in pulmonary pathology alongside expert pat….
0
6
0
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
RT @rovingatuscap: Research Presentations CONTINUE on Monday 3/24 #USCAP2025 . Highlighting the work of @MSKPathology @MSKCancerCenter Fell….
0
4
0
@natasharekhtman
Natasha Rekhtman MD PhD
4 months
Attending #USCAP2025?.Don’t miss the Pulmonary Evening Conference. Mon March 24, 7-8:30 pm. We have a fantastic line-up of speakers discussing cool cases. See you there!
Tweet media one
Tweet media two
3
12
39
@natasharekhtman
Natasha Rekhtman MD PhD
5 months
Please vote 👇! This is a "bracket-style" competition of biomedical studies. Everyone is a winner here - this is just a fun way to raise awareness of the "competing" studies. Honored to represent @MSKCancerCenter with our study on chromothripsis-mediated #SCLC.
@MSKCancerCenter
Memorial Sloan Kettering Cancer Center
5 months
Congratulations to MSK's @natasharekhtman and @charlesrudin for being accepted into Round 1 of @statnews #STATMadness. Vote for the team “New Lung Cancer Subtype” now:
Tweet media one
0
6
29
@natasharekhtman
Natasha Rekhtman MD PhD
5 months
Thank you @drshieldsmd for a great conversation. Was a true honor to be a guest on @SclcSMASHERS and to shed the light on the role of #pathologists in the care of patients with #SCLC.
@drshieldsmd
Misty Dawn Shields
5 months
A true privilege to interview two incredible guests, Drs. Marina Baine @mkbaine & Natasha Rekhtman @natasharekhtman from @MSKPathology @MSKCancerCenter on the @SclcSMASHERS Fireside Chat Speaker Series w/ @LUNGevity.
Tweet media one
0
2
6
@natasharekhtman
Natasha Rekhtman MD PhD
5 months
Look forward to being a guest on @LUNGevity's @SclcSMASHERS with my colleague Marina Baine @mkbaine. Thank you, Misty Shields @drshieldsmd and Ann Steagall, for inviting us to discuss the role of pathologists in the diagnosis of #SCLC and the latest advances.
@LUNGevity
LUNGevity Foundation
5 months
Join us for our next @sclcsmashers Fireside Chat w/ Dr. Marina Baine & Dr. Natasha Rekhtman on 2/28 to discuss the role of a pathologist in #SCLC, why the right diagnosis is key, logistics and importance of pathology/biopsies. Tune in at
Tweet media one
Tweet media two
0
2
5
@natasharekhtman
Natasha Rekhtman MD PhD
6 months
Thrilled to see the final version of our paper on chromothripsis-mediated small cell lung carcinoma #SCLC in the current issue of @CD_AACR. Many thanks to Cancer Discovery Editors for featuring this article in the “spotlight” section!.
Tweet card summary image
aacrjournals.org
This study describes an exceptional, alternative pathway of SCLC pathogenesis via chromothripsis and ecDNA in the absence of RB1 and TP53 mutations or smoking mutagenesis, defining a novel tumor type...
@CD_AACR
Cancer Discovery
6 months
From the January issue: #Chromothripsis-mediated Small Cell Lung Carcinoma @natasharekhtman @SamTTweets @ChrisFebres @charlesrudin @MSKCancerCenter #SCLC
Tweet media one
0
11
50
@natasharekhtman
Natasha Rekhtman MD PhD
6 months
Many thanks to @BenDrapkinand and Urooba Nadeem for the great editorial and figure about our recent @CD_AACR article on the novel type of small cell lung carcinoma #SCLC.
Tweet media one
Tweet media two
Tweet media three
0
8
36